| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |